News: PKS Pks Holdings Executes Abbott Software License And Distribution Agreement, page-17

Massive market here with some big players such a cerner truven etc. pks have clever niche product which can be used for simple things like real time auditing patient details to avoid duplicate testing and allocating the test to the wrong pt (it happens ) or scaled up to a hybrid type deep learning AI for clinical support. The applications for ripple down are massive and they are already part or the phillips and abbott ecosystem. The new abbott detail is also a game changer moving from single subscription to a volume model. Already fairly valued with no growth baked in. Undervalued IMO.